Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1990 Apr;136(4):923–931.

Alveolar type II cell response in rats exposed to aerosols of alpha-cristobalite.

R B Low 1, K O Leslie 1, D R Hemenway 1, M Absher 1, K B Adler 1, M S Giancola 1, P M Vacek 1
PMCID: PMC1877647  PMID: 2158238

Abstract

Alpha-cristobalite causes pulmonary interstitial disease in humans and experimental animals. Aerosol exposure of rats to cristobalite for 8 days results in early and sustained alveolar type II cell hyperplasia in areas of inflammation characterized by the presence of macrophages and polymorphonuclear leukocytes. Irregular interstitial fibrosis and coalescence of alveoli are apparent by day 120. The inflammatory response is characterized by increased lavage cell recoveries, principally macrophages and neutrophils. Lavage recoveries of protein, nonpolar lipid, phospholipid, and saturated phosphatidylcholine also are increased. The recovery ratio for two important surfactant phospholipids, phosphatidylcholine and phosphatidylglycerol, is decreased at all points following exposure. Our morphologic analyses, together with results correlating lavage cell and lipid recoveries, point to the potential importance of macrophages and neutrophils in the epithelial cell response to cristobalite exposure.

Full text

PDF
923

Images in this article

924Figure 1
on p.924
926Figure 2
on p.926

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Absher M. P., Trombley L., Hemenway D. R., Mickey R. M., Leslie K. O. Biphasic cellular and tissue response of rat lungs after eight-day aerosol exposure to the silicon dioxide cristobalite. Am J Pathol. 1989 Jun;134(6):1243–1251. [PMC free article] [PubMed] [Google Scholar]
  2. Adamson I. Y., Young L., Bowden D. H. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol. 1988 Feb;130(2):377–383. [PMC free article] [PubMed] [Google Scholar]
  3. Ansfield M. J., Benson B. J. Identification of the immunosuppressive components of canine pulmonary surface active material. J Immunol. 1980 Sep;125(3):1093–1098. [PubMed] [Google Scholar]
  4. Ansfield M. J., Kaltreider H. B., Benson B. J., Caldwell J. L. Immunosuppressive activity of canine pulmonary surface active material. J Immunol. 1979 Mar;122(3):1062–1066. [PubMed] [Google Scholar]
  5. Ansfield M. J., Kaltreider H. B., Benson B. J., Shalaby M. R. Canine surface active material and pulmonary lymphocyte function. Studies with mixed-lymphocyte culture. Exp Lung Res. 1980 Mar;1(1):3–11. doi: 10.3109/01902148009057508. [DOI] [PubMed] [Google Scholar]
  6. Beck B. D., Brain J. D., Bohannon D. E. An in vivo hamster bioassay to assess the toxicity of particulates for the lungs. Toxicol Appl Pharmacol. 1982 Oct;66(1):9–29. doi: 10.1016/0041-008x(82)90057-6. [DOI] [PubMed] [Google Scholar]
  7. Beppu O. S., Clements J. A., Goerke J. Phosphatidylglycerol-deficient lung surfactant has normal properties. J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):496–502. doi: 10.1152/jappl.1983.55.2.496. [DOI] [PubMed] [Google Scholar]
  8. Bégin R., Possmayer F., Ormseth M. A., Martel M., Cantin A., Massé S. Effect of aluminum inhalation on alveolar phospholipid profiles in experimental silicosis. Lung. 1989;167(2):107–115. doi: 10.1007/BF02714937. [DOI] [PubMed] [Google Scholar]
  9. Chander A., Claypool W. D., Jr, Strauss J. F., 3rd, Fisher A. B. Uptake of liposomal phosphatidylcholine by granular pneumocytes in primary culture. Am J Physiol. 1983 Nov;245(5 Pt 1):C397–C404. doi: 10.1152/ajpcell.1983.245.5.C397. [DOI] [PubMed] [Google Scholar]
  10. Cooper W. C., Sargent E. N. A 26-year radiographic follow-up of workers in a diatomite mine and mill. J Occup Med. 1984 Jun;26(6):456–460. doi: 10.1097/00043764-198406000-00019. [DOI] [PubMed] [Google Scholar]
  11. Crapo J. D., Barry B. E., Foscue H. A., Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis. 1980 Jul;122(1):123–143. doi: 10.1164/arrd.1980.122.1.123. [DOI] [PubMed] [Google Scholar]
  12. Dethloff L. A., Gilmore L. B., Brody A. R., Hook G. E. Induction of intra- and extra-cellular phospholipids in the lungs of rats exposed to silica. Biochem J. 1986 Jan 1;233(1):111–118. doi: 10.1042/bj2330111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dethloff L. A., Gilmore L. B., Gladen B. C., George G., Chhabra R. S., Hook G. E. Effects of silica on the composition of the pulmonary extracellular lining. Toxicol Appl Pharmacol. 1986 Jun 15;84(1):66–83. doi: 10.1016/0041-008x(86)90417-5. [DOI] [PubMed] [Google Scholar]
  14. Dutra F. R. Diatomaceous earth pneumoconiosis. Arch Environ Health. 1965 Nov;11(5):613–619. doi: 10.1080/00039896.1965.10664269. [DOI] [PubMed] [Google Scholar]
  15. Gabor S., Zugravu E., Kováts A., Böhm B., Andrasoni D. Effects of quartz on lung surfactant. Environ Res. 1978 Jul;16(1-3):443–448. doi: 10.1016/0013-9351(78)90177-9. [DOI] [PubMed] [Google Scholar]
  16. Grünspan M., Antweiler H., Dehnen W. Effect of silica on phospholipids in the rat lung. Br J Ind Med. 1973 Jan;30(1):74–77. doi: 10.1136/oem.30.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hallman M., Enhorning G., Possmayer F. Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant. Pediatr Res. 1985 Mar;19(3):286–292. doi: 10.1203/00006450-198503000-00006. [DOI] [PubMed] [Google Scholar]
  18. Hallman M., Spragg R., Harrell J. H., Moser K. M., Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest. 1982 Sep;70(3):673–683. doi: 10.1172/JCI110662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hart B. A., Harmsen A. G., Low R. B., Emerson R. Biochemical, cytological, and histological alterations in rat lung following acute beryllium aerosol exposure. Toxicol Appl Pharmacol. 1984 Sep 30;75(3):454–465. doi: 10.1016/0041-008x(84)90182-0. [DOI] [PubMed] [Google Scholar]
  20. Haschek W. M., Witschi H. Pulmonary fibrosis--a possible mechanism. Toxicol Appl Pharmacol. 1979 Dec;51(3):475–487. doi: 10.1016/0041-008x(79)90372-7. [DOI] [PubMed] [Google Scholar]
  21. Hass M. A., Longmore W. J. Surfactant cholesterol metabolism of the isolated perfused rat lung. Biochim Biophys Acta. 1979 Apr 27;573(1):166–174. doi: 10.1016/0005-2760(79)90183-8. [DOI] [PubMed] [Google Scholar]
  22. Hemenway D. R., MacAskill S. M. Design, development and test results of a horizontal flow inhalation toxicology facility. Am Ind Hyg Assoc J. 1982 Dec;43(12):874–879. doi: 10.1080/15298668291410738. [DOI] [PubMed] [Google Scholar]
  23. Heppleston A. G., Fletcher K., Wyatt I. Changes in the composition of lung lipids and the "turnover" of dipalmitoyl lecithin in experimental alveolar lipo-proteinosis induced by inhaled quartz. Br J Exp Pathol. 1974 Aug;55(4):384–395. [PMC free article] [PubMed] [Google Scholar]
  24. Heppleston A. G. The fibrogenic action of silica. Br Med Bull. 1969 Sep;25(3):282–287. doi: 10.1093/oxfordjournals.bmb.a070719. [DOI] [PubMed] [Google Scholar]
  25. Heppleston A. G., Young A. E. Alveolar lipo-proteinosis: an ultrastructural comparison of the experimental and human forms. J Pathol. 1972 Jun;107(2):107–117. doi: 10.1002/path.1711070205. [DOI] [PubMed] [Google Scholar]
  26. Hildebran J. N., Goerke J., Clements J. A. Pulmonary surface film stability and composition. J Appl Physiol Respir Environ Exerc Physiol. 1979 Sep;47(3):604–611. doi: 10.1152/jappl.1979.47.3.604. [DOI] [PubMed] [Google Scholar]
  27. Hughes D. A., Haslam P. L. Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis. Chest. 1989 Jan;95(1):82–89. doi: 10.1378/chest.95.1.82. [DOI] [PubMed] [Google Scholar]
  28. Jacobs H., Jobe A., Ikegami M., Miller D., Jones S. Reutilization of phosphatidylcholine analogues by the pulmonary surfactant system. The lack of specificity. Biochim Biophys Acta. 1984 Apr 18;793(2):300–309. doi: 10.1016/0005-2760(84)90333-3. [DOI] [PubMed] [Google Scholar]
  29. Kawada H., Horiuchi T., Shannon J. M., Kuroki Y., Voelker D. R., Mason R. J. Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in the rat. Am Rev Respir Dis. 1989 Aug;140(2):460–470. doi: 10.1164/ajrccm/140.2.460. [DOI] [PubMed] [Google Scholar]
  30. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  31. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  32. Liau D. F., Barrett C. R., Bell A. L., Cernansky G., Ryan S. F. Diphosphatidylglycerol in experimental acute alveolar injury in the dog. J Lipid Res. 1984 Jul;25(7):678–683. [PubMed] [Google Scholar]
  33. Liau D. F., Barrett C. R., Bell A. L., Ryan S. F. Functional abnormalities of lung surfactant in experimental acute alveolar injury in the dog. Am Rev Respir Dis. 1987 Aug;136(2):395–401. doi: 10.1164/ajrccm/136.2.395. [DOI] [PubMed] [Google Scholar]
  34. Low R. B., Adler K. B., Woodcock-Mitchell J., Giancola M. S., Vacek P. M. Bronchoalveolar lavage lipids during development of bleomycin-induced fibrosis in rats. Relationship to altered epithelial cell morphology. Am Rev Respir Dis. 1988 Sep;138(3):709–713. doi: 10.1164/ajrccm/138.3.709. [DOI] [PubMed] [Google Scholar]
  35. Low R. B., Davis G. S., Bell D. Y., Giancola M. S., Vacek P. M. Lipids in bronchoalveolar lavage fluid from patients with sarcoidosis. Thorax. 1987 Dec;42(12):926–932. doi: 10.1136/thx.42.12.926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Low R. B., Davis G. S., Giancola M. S. Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers. Am Rev Respir Dis. 1978 Nov;118(5):863–875. doi: 10.1164/arrd.1978.118.5.863. [DOI] [PubMed] [Google Scholar]
  37. Mason R. J., Nellenbogen J., Clements J. A. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res. 1976 May;17(3):281–284. [PubMed] [Google Scholar]
  38. Miller B. E., Dethloff L. A., Hook G. E. Silica-induced hypertrophy of type II cells in the lungs of rats. Lab Invest. 1986 Aug;55(2):153–163. [PubMed] [Google Scholar]
  39. Reiser K. M., Last J. A. Silicosis and fibrogenesis: fact and artifact. Toxicology. 1979 May;13(1):51–72. [PubMed] [Google Scholar]
  40. Richards R. J., Curtis C. G. Biochemical and cellular mechanisms of dust-induced lung fibrosis. Environ Health Perspect. 1984 Apr;55:393–416. doi: 10.1289/ehp.8455393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Robinson P. C., Watters L. C., King T. E., Mason R. J. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis. 1988 Mar;137(3):585–591. doi: 10.1164/ajrccm/137.3.585. [DOI] [PubMed] [Google Scholar]
  42. Rooney S. A. The surfactant system and lung phospholipid biochemistry. Am Rev Respir Dis. 1985 Mar;131(3):439–460. doi: 10.1164/arrd.1985.131.3.439. [DOI] [PubMed] [Google Scholar]
  43. Staub N. C. Pulmonary edema. Physiol Rev. 1974 Jul;54(3):678–811. doi: 10.1152/physrev.1974.54.3.678. [DOI] [PubMed] [Google Scholar]
  44. Tetley T. D., Richards R. J., Harwood J. L. Changes in pulmonary surfactant and phosphatidylcholine metabolism in rats exposed to chrysotile asbestos dust. Biochem J. 1977 Sep 15;166(3):323–329. doi: 10.1042/bj1660323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Thrall R. S., Swendsen C. L., Shannon T. H., Kennedy C. A., Frederick D. S., Grunze M. F., Sulavik S. B. Correlation of changes in pulmonary surfactant phospholipids with compliance in bleomycin-induced pulmonary fibrosis in the rat. Am Rev Respir Dis. 1987 Jul;136(1):113–118. doi: 10.1164/ajrccm/136.1.113. [DOI] [PubMed] [Google Scholar]
  46. Wray W., Boulikas T., Wray V. P., Hancock R. Silver staining of proteins in polyacrylamide gels. Anal Biochem. 1981 Nov 15;118(1):197–203. doi: 10.1016/0003-2697(81)90179-2. [DOI] [PubMed] [Google Scholar]
  47. Wright J. R., Benson B. J., Williams M. C., Goerke J., Clements J. A. Protein composition of rabbit alveolar surfactant subfractions. Biochim Biophys Acta. 1984 Dec 21;791(3):320–332. doi: 10.1016/0167-4838(84)90343-1. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES